Biocept, Inc. is an oncology laboratory service company, which engages in the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. The company is headquartered in San Diego, California and currently employs 50 full-time employees. The company went IPO on 2014-02-05. The firm has developed a patented methodology to isolate cancer material that is shed from the primary tumor, such as CSF tumor cells (CSF-TCs) and cell-free DNA (cfDNA). As such, it is a commercial provider of testing services designed to enable clinicians to rapidly detect and monitor cancer biomarkers from a cerebrospinal fluid sample. The firm operates a clinical laboratory and manufactures cell enrichment and extraction microfluidic channels, related equipment and certain reagents to perform the Company’s diagnostic assays in a facility located in San Diego, California. The assays the Company offers are classified as laboratory developed tests (LDT) under the CLIA regulations. The Company’s assays, performed on cerebral spinal fluid, have the potential to provide more contemporaneous information on the characteristics of a patient’s disease.
Sur la base des 9 analystes attribuant des notes à l'action BIOCQ, mis à jour le Jan 01, 2024
Sell
Strong buy
0
Buy
0
Hold
4
Sell
2
Strong sell
3
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for BIOCQ. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: BIOCQ is a Sell candidate.
BIOCQ stock price ended at $0 on jeudi, after rising NaN%
On the latest trading day Jan 15, 2026, the stock price of BIOCQ rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 3.5K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 4.5K shares were traded, equating to a market value of approximately --.
Signaux Techniques de BIOCQ
Résumé des Signaux Techniques
Acheter des signaux 1
Signaux neutres 6
Signaux de vente 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
BIOCQ présente actuellement 1 signaux d'achat et 0 signaux de vente. L'action est en tendance haussière depuis 12:00 AM, avec une variation totale du prix de -- pendant cette période. En général, les indicateurs techniques indiquent une tendance Buy à moyen terme.
Signaux haussiers/baissiers pour BIOCQ
Nous analysons les indicateurs clés comme les moyennes mobiles, le RSI, le MACD et le volume de transactions pour générer des signaux haussiers et baissiers pour BIOCQ, vous aidant à prendre des décisions d'investissement éclairées.
Questions complémentaires
Comment les indicateurs d'analyse technique s'appliquent-ils à BIOCQ ?
Quels sont les niveaux de retracement de Fibonacci pour BIOCQ ?
Quel est le RSI de Biocept Inc ?
Quel est le prix de Biocept Inc pour les 12 prochains mois ?